Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
AVUS vs XLV: how they differ
AVUS and XLV hold 6% of their weight in the same names, and AVUS returned more over the year.
Avantis U.S. Equity ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, AVUS and XLV hold 6% of their money in the same securities at the same weight.
| Holding | AVUS | XLV |
|---|---|---|
| Eli Lilly & Co | 0.84% | 16.56% |
| Merck & Co Inc | 0.63% | 5.54% |
| Johnson & Johnson | 0.58% | 10.67% |
| Gilead Sciences Inc | 0.45% | 2.74% |
| AbbVie Inc | 0.34% | 7.76% |
| Amgen Inc | 0.20% | 3.41% |
| Pfizer Inc | 0.18% | 2.40% |
| UnitedHealth Group Inc | 0.17% | 6.59% |
| Bristol-Myers Squibb Co | 0.15% | 2.05% |
| Centene Corp | 0.14% | 0.53% |
| Vertex Pharmaceuticals Inc | 0.14% | 2.20% |
| Elevance Health Inc | 0.14% | 1.47% |
| Only in AVUS | Only in XLV |
|---|---|
| NVIDIA Corp 5.49% | Medtronic PLC 1.75% |
| Apple Inc 5.37% | Becton Dickinson & Co 0.73% |
| Microsoft Corp 3.85% | GE HealthCare Technologies Inc 0.51% |
| Amazon.com Inc 3.68% | Quest Diagnostics Inc 0.41% |
| Alphabet Inc 2.42% | STERIS PLC 0.36% |
| Micron Technology Inc 2.40% | Revvity Inc 0.22% |
| Meta Platforms Inc 2.21% | Henry Schein Inc 0.14% |
| Alphabet Inc 1.94% | DaVita Inc 0.12% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| AVUS Avantis U.S. Equity ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Avantis | State Street |
| What it is | U.S. Equity | Health care |
| Total return, 1 year | +21.6% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +4.1 pts | +2.9 pts |
| Expense ratio | 0.15% | 0.08% |
| Already in the S&P 500 | 84.4% | 100.0% |
| Holdings | 1875 | 59 |
AVUS in plain words
AVUS is an index equity fund tracking the U.S. Equity. Over the year to Sep 11, 2026 it returned +21.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year. By its holdings filed for May 31, 2026, 84% of the fund by weight is stocks the S&P 500 also holds, across 1875 positions, with the top ten at 29.7%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, AVUS or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, AVUS returned +21.6% and XLV returned +20.4%, so AVUS returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, AVUS or XLV?
- AVUS charges 0.15% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do AVUS and XLV overlap with the S&P 500?
- By their latest filed holdings, 84% of AVUS and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 6% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, AVUS against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/AVUS-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources